Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Kōtō City
Clinical trial register · Japan

Clinical Trials in Kōtō City, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Japan and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2516 matching records held by the registry are in this view. Synced 12 Nov 2026, 03:19 UTC
2516
Studies in scope
all four open statuses
1285
Recruiting now
open to new participants
352
Lead sponsors
across recruiting studies
Top sites
Fukuoka 557 Nagoya 513 Sapporo 400 Tokyo 375 Osaka 354
Narrow the registerReset
Recruitment status
Phase
Target enrolment
to

Trials with a site in Kōtō City

10 of 2516 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Japan
Start
Recruiting
Stemline Therapeutics, Inc.
Phase 2
70
Chiba, Fukuoka, Hirakata, Hiroshima, Ina, Isehara, Kagoshima, Kōtō City
2026-08-18
Recruiting
Eli Lilly and Company
Phase 3
1,000
Fukuoka, Hakata-Ku, Hino, Karatsu, Kawasaki, Kitakyushu, Koshigaya, Kōtō City
2026-08-14
Recruiting
Eli Lilly and Company
Phase 2
400
Chikugo, Chiyoda City, Fukushima, Iruma, Karatsu, Kōtō City, Kumamoto, Kure
2025-11-24
Active, closed
Arcus Biosciences, Inc.
Phase 3
610
Kashiwa-shi, Kōtō City, Osaka, Tokyo, Toyama, Ube, Yokohama
2024-12-13
Active, closed
A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
NCT06561685Metastatic Solid Tumor, Advanced Solid Tumor, Non-small Cell Lung Cancer, SMARCA4-Deficient Tumor
Eli Lilly and Company
Phase 1
340
Chūōku, Kashiwa, Kōtō City, Nagaizumi-cho,Sunto-gun
2024-09-19
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
NCT06465069Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
460
Chūōku, Kashiwa, Chiba, Kōtō City, Nagoya
2024-07-01
Active, closed
A Study of LY4101174 in Participants With Recurrent, Advanced or Metastatic Solid Tumors
NCT06238479Metastatic Solid Tumor, Recurrent Solid Tumor, Advanced Solid Tumor, Urinary Bladder Neoplasm
Eli Lilly and Company
Phase 1
490
Chūōku, Kashiwa, Kōtō City, Kyoto
2024-03-05
Recruiting
Eli Lilly and Company
Phase 1/2
880
Fukuoka, Hirakata, Kōtō City, Kyoto
2023-04-17
Active, closed
Eli Lilly and Company
Phase 1
260
Chūōku, Kōtō City, Kyoto, Nagoya
2022-05-11
Active, closed
Loxo Oncology, Inc.
Phase 3
600
Bunkyō City, Chiba-Ken, Chūō, Chūōku, Fukui, Kōtō City, Kyoto, Nankoku
2021-09-20
Rows per page Showing 1–10 of 10
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Japanese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 14 November 2026. https://priyalifescience.com/clinical-trials-japan/city/k-t-city

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Japan and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,516 studies in total at the last sync on 12 Nov 2026, 03:19 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 10 of those studies with a site in Kōtō City.

How many clinical trials are recruiting in Kōtō City?

5 of the 10 studies on this page are recruiting new participants as of the 12 Nov 2026, 03:19 UTC sync. A further 0 have not yet opened recruitment, 5 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Kōtō City), 10 studies
PhaseStudiesRecruitingShare
Phase 14140%
Phase 33130%
Phase 22220%
Phase 1/21110%

Most active sponsors

Lead sponsors with the most studies (Kōtō City)
Lead sponsorStudiesRecruiting
Eli Lilly and Company74
Arcus Biosciences, Inc.10
Loxo Oncology, Inc.10
Stemline Therapeutics, Inc.11
→

Other trial registries in Japan

This register lists Japan studies from ClinicalTrials.gov. Many studies in Japan are registered only in a national registry. We do not copy those records; search them directly:

  • jRCT (Japan Registry of Clinical Trials) — run by the Ministry of Health, Labour and Welfare; trials under Japan's Clinical Trials Act and other clinical research
  • UMIN-CTR — run by the University of Tokyo Hospital's UMIN Center; many academic and investigator-led studies
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.